• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Physitrack

7.70 SEK+1.05 %16.7. klo 18.29
Less than 1K followers

PTRK

First North Stockholm

Software

Technology

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.05 %
0.00 %
-12.50 %
-35.56 %
-41.22 %
-46.90 %
-50.00 %
-87.58 %
-83.44 %

Physitrack operates in the healthcare sector and specializes in physiotherapy. The product portfolio includes digital healthcare offerings for companies via SaaS solutions. In addition to the main business, personal service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe and North America. Physitrack was founded in 2012 and is headquartered in London.

Read more
Market cap
125.21M SEK
Turnover
26.18K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Forum discussions
Stable storage.mfn.se q1-2026-interim-report-v1.pdf Summary for the period First quarter: 1 January – 31 March 2026 Based on Alternative Key Performance Measures, the Company’s key financial highlights for the period are summarised below. Constant currency revenue amounted to EUR...
4/23/2026, 11:30 AM
by kettunen
3
True, it’s stable. Fortunately, we are slowly drifting forward anyway. I’d prefer to see slightly stronger figures before the US listings. By the way, we’ve drifted quite close to Redeye’s bear case again: Physitrack - Redeye Are there any other analysts still covering this?
5/4/2026, 1:23 PM
by Von Wangell
2
Permission received from the lender to start the program Physitrack PLC receives lender consent for share buyback program Physitrack PLC (Nasdaq First North: PTRK) (“Physitrack” or the “Company”) today announces that it has received the necessary consent from its banking partner ...
4/9/2026, 4:18 PM
by kettunen
2
US market is open While not significant in value, the signal value for the future is very good. Physitrack signs Agreement with New York-based Academic Medical Center Physitrack PLC (Nasdaq First North Premier: PTRK) — New Commercial Agreement Generates $100,556 in Total Contract...
3/30/2026, 9:37 AM
by kettunen
2
I would hope for more deals on the wellness side so that its competitiveness and demand would be proven. This will do for now while waiting for those Physitrack announces agreement with leading Swiss healthcare organisation Physitrack PLC (Nasdaq First North Premier: PTRK) has reached...
3/10/2026, 4:11 PM
by kettunen
2
A Q4 update fairly in line with expectations. Official and audited figures will follow later. Growth is needed; profitability is significantly better. storage.mfn.se pdf-report-physitrack-plc-unaudited-fy2025-trading-update-and-preliminary-results.pdf CEO Henrik’s interview https...
1/29/2026, 8:02 AM
by kettunen
2
Small fish in a big pond… Physitrack Agrees Deal to Launch Digital Rehabilitation Across Major UK Healthcare Provider’s National Network The deal entails enterprise-wide standardisation across 37 clinical sites and approximately 400 practitioner licences nationwide. Approximately...
6/30/2026, 4:31 PM
by kettunen
1
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
21.7.
2026

Interim report Q2'26

20.10.
2026

Interim report Q3'26

26.2.
2027

Annual report '26

Press release14.07.2026 klo 09.30

Invitation to Physitrack PLC Q2 2026 interim report webcast conference

Physitrack
Press release01.07.2026 klo 10.00

Physitrack Announces Five-Year Enterprise Agreement with Leading UK Private Hospital Network

Physitrack
Press release30.06.2026 klo 18.00

Physitrack Agrees Deal to Launch Digital Rehabilitation Across Major UK Healthcare Provider's National Network

Physitrack

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release29.06.2026 klo 09.30

Physitrack PLC — Notification of Managers' Transactions

Physitrack
Regulatory press release26.05.2026 klo 20.00

Bulletin from Physitrack PLC's (publ) Annual General Meeting and General Meeting

Physitrack
Press release14.05.2026 klo 17.30

Physitrack PLC – Champion Health Signs Deal with Triple Dot Studios

Physitrack
Regulatory press release11.05.2026 klo 09.30

Physitrack Plc: Proposed Appointment of Auditor

Physitrack
Regulatory press release08.05.2026 klo 12.30

Physitrack Plc: Notice of General Meeting

Physitrack
Press release27.04.2026 klo 16.45

Physitrack Plc Lands New Deal with UK NHS Trust

Physitrack
Press release24.04.2026 klo 10.37

Redeye: Physitrack (Q1 Review): Enters a new growth phase

Physitrack
Press release24.04.2026 klo 10.32

Redeye: Physitrack (Q1 Interview): Growth pivot starts here; RTM to lead the US offensive

Physitrack
Regulatory press release23.04.2026 klo 12.20

Correction: Physitrack Plc: Interim Report Q1 2026 – Stable Profitability, RTM Launch and a New Chapter for North American Expansion

Physitrack
Press release23.04.2026 klo 10.40

Redeye: Physitrack (Q1 Initial take): Results close to expectations; RTM and US listing in focus

Physitrack
Regulatory press release23.04.2026 klo 09.00

Physitrack Plc: Delårsrapport Q1 2026 – Stabil lönsamhet, RTM-lansering och ett nytt kapitel för expansion i Nordamerika

Physitrack
Regulatory press release23.04.2026 klo 09.00

Physitrack Plc: Interim Report Q1 2026 – Stable Profitability, RTM Launch and a New Chapter for North American Expansion

Physitrack
Regulatory press release21.04.2026 klo 09.00

Physitrack Plc: Notice of Annual General Meeting

Physitrack
Press release16.04.2026 klo 09.30

Invitation to Physitrack PLC Q1 2026 interim report webcast conference

Physitrack
Press release09.04.2026 klo 17.45

Physitrack PLC receives lender consent for share buyback program

Physitrack
Press release08.04.2026 klo 09.59

Redeye: Physitrack (Q1 Preview): Focus on margin resilience and growth inflection

Physitrack
Press release01.04.2026 klo 09.30

Physitrack: Champion Health in New Agreement with UK Enterprise Employer

Physitrack